From the Maine Department of Education Reporting Items | Visit the DC&R Reporting Calendar | News & Updates Media Release: Maine DOE Launches New Podcast Highlighting Voices From Maine Schools The Maine Department of Education (DOE) launched a new podcast today hosted by Commissioner Pender Makin featuring conversations with educators, school staff, and students. The … Continue reading Maine DOE Update: October 20, 2023
As a result of the First Special Session of the 131st Maine Legislature, Resolves 2023, Chapter 44, “Resolve, Directing the Department of Education and the Maine Municipal Bond Bank to Amend Their Rules Regarding the Maine School Facilities Finance Program and the School Revolving Renovation Fund” effective October 25, 2023 directs the Maine Department of … Continue reading PUBLIC COMMENT: Filing of Targeted Revisions to Rule Chapter 64: Maine School Facilities Program and School Revolving Renovation Fund
Govt Release Strategic Priority Five Summary bernews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bernews.com Daily Mail and Mail on Sunday newspapers.
Priorities Regarding the New and Emerging Challenges to International Security - United States Department of State state.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from state.gov Daily Mail and Mail on Sunday newspapers.
But a return to normal for Klamath County is still a long way off.
Two Legacy Health facilities in the Portland area each received 975 doses of the vaccine on Monday, and two more facilities in Portland and one in Ontario will each receive the same amount on Tuesday. The Oregon Health Authority said it will distribute a total of 35,100 doses to hospitals and 10,725 doses to skilled nursing facilities throughout the state this week. Two more shipments in December will provide an additional 63,300 doses.
Developed with German company BioNTech, Pfizer’s vaccine was found to be 95% effective in Phase 3 clinical trials that enrolled almost 44,000 people. The FDA’s standard for issuing an emergency use authorization for vaccines is 50% effectiveness.